EP1578439A4

Low dose methods for treating disorders in which tnf-alpha activity is detrimental

Abstract

This record has no abstract on file.

EP1578439A4, drawing sheet 1 — Sheet 1 of 8

Term

Term ended

Projected expiry passed 24 October 2023, 2.9 years ago.

8 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8

Every citation, both waysCites: the store holds 4 of 5

Citations
Document	Relation	Office	Category	Cited during	Relevant claims
WO02100330A2	Cites	World Intellectual Property Organization (WIPO)	PX	Search report	1-5,7-12,14-18,20-25,27-31
US2001026801A1	Cites	United States of America	X	Search report	1-30
GB2279077A	Cites	United Kingdom	A	Search report	–
WO02100330A	Cites	World Intellectual Property Organization (WIPO)	–	–	–
BAUGH J A ET AL: "MECHANISMS FOR MODULATING TNFALPHA IN IMMUNE AND INFLAMMATORY DISEASE", CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT, CURRENT DRUGS, LONDON, GB, vol. 4, no. 5, 2001, pages 635 - 650, XP001145475, ISSN: 1367-6733	Non-patent	–	–	Search report	–
KEMPENI J: "Preliminary results of early clinical trials with the fully human anti-TNFalpha monoclonal antibody D2E7", ANNALS OF THE RHEUMATIC DISEASES, BRITISH MEDICAL ASSOCIATION, LONDON, GB, vol. 58, no. 3, 1999, pages I70 - I72, XP002979958, ISSN: 0003-4967	Non-patent	–	–	Search report	–
ELLIOTT MICHAEL J ET AL: "Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis", LANCET, LITTLE, BROWM AND CO., BOSTON,, US, vol. 344, no. 8930, 1994, pages 1105 - 1110, XP002172700, ISSN: 0099-5355	Non-patent	–	–	Search report	–
LORENZ H-M: "BIOLOGICAL AGENTS: A NOVEL APPROACH TO THE THERAPY OF RHEUMATOID ARTHRITIS", EXPERT OPINION ON INVESTIGATIONAL DRUGS, ASHLEY PUBLICATIONS LTD., LONDON, GB, vol. 9, no. 7, 2000, pages 1479 - 1490, XP000945095, ISSN: 1354-3784	Non-patent	–	–	Search report	–
LOVELL DANIEL J ET AL: "Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.", ARTHRITIS AND RHEUMATISM. JAN 2003, vol. 48, no. 1, January 2003 (2003-01-01), pages 218 - 226, XP002369192, ISSN: 0004-3591	Non-patent	–	–	Search report	–
LORENZ HANNS-MARTIN ET AL: "Perspectives for TNF-alpha-targeting therapies.", ARTHRITIS RESEARCH. 2002, vol. 4 Suppl 3, 2002, pages S17 - S24, XP002369193, ISSN: 1465-9905	Non-patent	–	–	Search report	–

449 members in 31 offices

This recordMember, by publication datePriority claim21 more offices are in the list below

Priority claims9

Priority claims
Document	Office	Kind	Date
421262P	United States of America	–	2002-10-24
42126202	United States of America	P	2002-10-24
42126202	United States of America	P	2002-10-24
0333973	United States of America	W	2003-10-24
0333973	United States of America	W	2003-10-24
421262P	–	–	–
US20020421262P	–	–	–
US2003033973	–	–	–
WO2003US33973	–	–	–

Members449

Family members, oldest first
Document	Office	Kind
CA2493067A1	Canada	A1	2004-01-29
CA2800126A1	Canada	A1	2004-01-29
CA2803741A1	Canada	A1	2004-01-29
CA2880296A1	Canada	A1	2004-01-29
CA2890586A1	Canada	A1	2004-01-29
WO2004009776A2	World Intellectual Property Organization (WIPO)	A2	2004-01-29
AU2003267999A1	Australia	A1	2004-02-09
CA2497909A1	Canada	A1	2004-05-06
WO2004037205A2	World Intellectual Property Organization (WIPO)	A2	2004-05-06
AU2003301522A1	Australia	A1	2004-05-13
UY28041A1	Uruguay	A1	2004-05-31
US2004126372A1	United States of America	A1	2004-07-01
US2004126373A1	United States of America	A1	2004-07-01
US2004131614A1	United States of America	A1	2004-07-08
US2004136989A1	United States of America	A1	2004-07-15
US2004136990A1	United States of America	A1	2004-07-15
US2004136991A1	United States of America	A1	2004-07-15
TW200412998A	Taiwan Province of China	A	2004-08-01
TW200412999A	Taiwan Province of China	A	2004-08-01
US2004151722A1	United States of America	A1	2004-08-05
US2004166111A1	United States of America	A1	2004-08-26
WO2004009776A3	World Intellectual Property Organization (WIPO)	A3	2004-10-21
WO2004037205A3	World Intellectual Property Organization (WIPO)	A3	2004-10-28
US2004219142A1	United States of America	A1	2004-11-04
PE20040751A1	Peru	A1	2004-11-18
AR040603A1	Argentina	A1	2005-04-13
WO2004037205A8	World Intellectual Property Organization (WIPO)	A8	2005-04-14
MXPA05000815A	Mexico	A	2005-04-28
KR20050042466A	Republic of Korea	A	2005-05-09
EP1542720A2	European Patent Office (EPO)	A2	2005-06-22
MXPA05004344A	Mexico	A	2005-08-02
KR20050083805A	Republic of Korea	A	2005-08-26
BR0312785A	Brazil	A	2005-08-30
BR0315597A	Brazil	A	2005-09-06
CA2504868A1	Canada	A1	2005-09-26
CA2847142A1	Canada	A1	2005-09-26
CA2847331A1	Canada	A1	2005-09-26
CA2970891A1	Canada	A1	2005-09-26
EP1578439A2	European Patent Office (EPO)	A2	2005-09-28
CN1691963A	China	A	2005-11-02
AR045710A1	Argentina	A1	2005-11-09
PL374865A1	Poland	A1	2005-11-14
AU2005244261A1	Australia	A1	2005-11-24
WO2005110452A2	World Intellectual Property Organization (WIPO)	A2	2005-11-24
SA04240497A	Saudi Arabia	A	2005-12-03
PL376705A1	Poland	A1	2006-01-09
US2006009385A1	United States of America	A1	2006-01-12
EP1542720A4	European Patent Office (EPO)	A4	2006-01-18
ZA200500068B	South Africa	B	2006-01-25
CN1732015A	China	A	2006-02-08
JP2006506465A	Japan	A	2006-02-23
JP2006507286A	Japan	A	2006-03-02
EP1578439A4This record	European Patent Office (EPO)	A4	2006-04-26
WO2005110452A3	World Intellectual Property Organization (WIPO)	A3	2006-08-03
ZA200502983B	South Africa	B	2006-09-27
AU2006246721A1	Australia	A1	2006-11-23
CA2608728A1	Canada	A1	2006-11-23
CA2898009A1	Canada	A1	2006-11-23
CA2903138A1	Canada	A1	2006-11-23
WO2006125229A2	World Intellectual Property Organization (WIPO)	A2	2006-11-23
EP1737491A2	European Patent Office (EPO)	A2	2007-01-03
MXPA06011677A	Mexico	A	2007-01-23
KR20070012701A	Republic of Korea	A	2007-01-26
WO2006125229A8	World Intellectual Property Organization (WIPO)	A8	2007-02-22
US2007071747A1	United States of America	A1	2007-03-29
TW200716673A	Taiwan Province of China	A	2007-05-01
CN1988918A	China	A	2007-06-27
US2007202104A1	United States of America	A1	2007-08-30
BRPI0509326A	Brazil	A	2007-09-04
CA2564435A1	Canada	A1	2007-10-10
WO2007120626A2	World Intellectual Property Organization (WIPO)	A2	2007-10-25
WO2007120651A2	World Intellectual Property Organization (WIPO)	A2	2007-10-25
WO2007120656A2	World Intellectual Property Organization (WIPO)	A2	2007-10-25
WO2007120720A2	World Intellectual Property Organization (WIPO)	A2	2007-10-25
WO2007120823A2	World Intellectual Property Organization (WIPO)	A2	2007-10-25
WO2007120720A3	World Intellectual Property Organization (WIPO)	A3	2007-12-21
AU2007269791A1	Australia	A1	2008-01-10
CA2651992A1	Canada	A1	2008-01-10
CA2885759A1	Canada	A1	2008-01-10
CA2950817A1	Canada	A1	2008-01-10
WO2008005315A2	World Intellectual Property Organization (WIPO)	A2	2008-01-10
HK1104454A1	Hong Kong, China	A1	2008-01-18
JP2008502596A	Japan	A	2008-01-31
KR20080011665A	Republic of Korea	A	2008-02-05
MX2007014440A	Mexico	A	2008-02-11
EP1885397A2	European Patent Office (EPO)	A2	2008-02-13
WO2008005315A9	World Intellectual Property Organization (WIPO)	A9	2008-03-13
ZA200608097B	South Africa	B	2008-04-30
TW200819154A	Taiwan Province of China	A	2008-05-01
US2008118496A1	United States of America	A1	2008-05-22
WO2008063213A2	World Intellectual Property Organization (WIPO)	A2	2008-05-29
EP1737491A4	European Patent Office (EPO)	A4	2008-06-04
US2008131374A1	United States of America	A1	2008-06-05
US2008166348A1	United States of America	A1	2008-07-10
EP1944322A2	European Patent Office (EPO)	A2	2008-07-16
WO2007120651A3	World Intellectual Property Organization (WIPO)	A3	2008-07-31
US2008193466A1	United States of America	A1	2008-08-14
WO2007120823A3	World Intellectual Property Organization (WIPO)	A3	2008-10-02
WO2007120626A3	World Intellectual Property Organization (WIPO)	A3	2008-10-23
WO2008005315A3	World Intellectual Property Organization (WIPO)	A3	2008-11-13

Showing 100 of 449

113 legal events, as 19 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2022-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-02-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-01-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-12-21	Announcement of lapse in spainLapsedFD2A	FD2A	ES
2018-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-08-22	Lapsed because of non-payment of the annual feeLapsedMM	MM	BE
2018-07-31	Lapse of patentLapsedKO00	KO00	SI
2018-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-27	Notification of lapseLapsedST	ST	FR
2018-07-25	Patent lapsedLapsedMM4A	MM4A	IE
2018-07-02	Patent lapsed due to non-payment of maintenance feesLapsedMM4A	MM4A	SK
2018-06-15	Lapse because of not paying annual feesLapsedMM01	MM01	AT
2018-06-06	Lapsed because of non-payment of the annual feeLapsedMM	MM	NL
2018-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-05-31	Patent ceasedCeasedPL	PL	CH
2018-05-29	Ep patent has lapsedLapsedEUG	EUG	SE
2018-05-22	Ep patent lapsedLapsedEBP	EBP	DK
2018-05-15	Lapsed by not paying the annual feesLapsedMM4A	MM4A	EE
2018-05-01	Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119	R119	DE
2018-02-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-11-01	Surrender of patent (sect. 29/pat. act 1977)OFFER ACCEPTEDS29	S29	GB
2017-08-23	Surrender of patent (sect. 29/pat. act 1977)OFFER FILED; APPLICATION FILED 19 JULY 2017S29	S29	GB
2017-02-28	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-02-28	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-02-28	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-02-28	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-02-28	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-02-28	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-01-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-01-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-01-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-01-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-01-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-01-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-01-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2017-01-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-12-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-12-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2016-09-26	Fee paymentPLFP	PLFP	FR
2014-09-15	Change of the firm name or firm addressHC	HC	AT
2014-09-04	Change of owner's nameTC4A	TC4A	SK
2014-07-15	Change of the address of the representativeNEW ADDRESS: HOLBEINSTRASSE 36-38, 4051 BASEL (CH)PCAR	PCAR	CH
2014-06-16	Change of owner nameHC1A	HC1A	EE
2014-05-30	Change of data on ownerSP73	SP73	SI
2014-05-09	Change of name or company nameCD	CD	FR
2014-04-17	Change of applicant/patenteeR081	R081	DE
2014-04-17	Change of applicant/patenteeR081	R081	DE
2014-04-17	Change of representativeR082	R082	DE
2014-04-17	Change of representativeR082	R082	DE
2014-04-17	Change of representativeR082	R082	DE
2014-04-02	Modifications of names of proprietors of patentsTD	TD	NL
2014-03-31	Name/firm changedPFA	PFA	CH
2014-03-28	Change of name, addressHC9C	HC9C	HU
2014-03-07	Change of representativeR082	R082	DE
2012-08-23	No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097	R097	DE
2012-07-04	No opposition filedOpposition26N	26N	EP
2012-06-01	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
2012-06-01	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
2012-05-02	Filing of the translation of the text of european patentsAG4A	AG4A	HU
2012-01-04	Translation of european patent specification into slovakT3	T3	SK
2011-12-15	Translation of the specification of european patent valid in estoniaFG4A	FG4A	EE
2011-12-14	Definitive protectionFG2A	FG2A	ES
2011-11-22	Ep patent validated in greeceEP	EP	GR
2011-11-09	Translation filed for an european patent granted for nl, confirming art. 52 par. 1 or 6 of the patents act 1995GrantedT3	T3	NL
2011-10-31	Ep patent with danish claimsT3	T3	DK
2011-10-27	Ep patent valid in romaniaEPE	EPE	RO
2011-10-25	Translation of granted ep patentGrantedTRGR	TRGR	SE
2011-10-19	Translation is availableAVAILABILITY OF NATIONAL TRANSLATIONSC4A	SC4A	PT
2011-09-22	Dpma publication of mentioned ep patent grantGrantedR096	R096	DE
2011-08-31	New agentNV	NV	CH

Showing 100 of 113

Low dose methods for treating disorders in which tnf-alpha activity is detrimental

Abstract

Term

Priority claims9

Members449

Over the term

Events

Numbers

Titles3

Classification

Designated states1